U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C9H11ClO3
Molecular Weight 202.635
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CHLORPHENESIN

SMILES

OCC(O)COC1=CC=C(Cl)C=C1

InChI

InChIKey=MXOAEAUPQDYUQM-UHFFFAOYSA-N
InChI=1S/C9H11ClO3/c10-7-1-3-9(4-2-7)13-6-8(12)5-11/h1-4,8,11-12H,5-6H2

HIDE SMILES / InChI

Molecular Formula C9H11ClO3
Molecular Weight 202.635
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Description
Curator's Comment: The description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/1271399 | https://www.ncbi.nlm.nih.gov/pubmed/24628968 | https://www.ncbi.nlm.nih.gov/pubmed/2941223 |

Chlorphenesin is a preservative and cosmetic biocide that helps prevent the growth of microorganisms. In cosmetics and personal care products, Chlorphenesin is used in the formulation of aftershave lotions, bath products, cleansing products, deodorants, hair conditioners, makeup, skin care products, personal cleanliness products, and shampoos. Chlorphenesin has been reported to cause irritation and contact dermatitis in some people, particularly those with sensitive and dry skin. The Cosmetic Ingredient Review (CIR) expert panel released a safety assessment in October 2012, however, that stated chlorphenesin at 0.3 percent (as it exists in personal care products) was classified as having “negligible dermal irritation potential.”

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Inactive ingredient
Volu-Firm

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Inhibition of histamine and SRS-A from monkey lung tissue by chlorophenesin.
1971 Aug
Effect of a muscle relaxant, chlorphenesin carbamate, on the spinal neurons of rats.
1984 Sep
Medical treatment of the major neuralgias.
1988 Dec
Patents

Patents

Sample Use Guides

The ingredient is allowed at up to 0.3 percent in cosmetic products in the U.S. and Europe.
Route of Administration: Topical
In Vitro Use Guide
The action of chlorphenesin on histamine release was investigated with isolated human leukocytes. Cells from ragweed or grass pollen sensitive donors were added to tubes containing a variable concentration of the chlorphenesin (2*10^-4-1*10^-3 M) and a constant concentration of ragweed antigen E or rye grass Group I antigen which was sufficient for 60% to 80% histamine release. A chlorphenesin concentration of between 0.3 and 0.6 mM causes 50 % inhibition.
Substance Class Chemical
Created
by admin
on Fri Dec 15 16:33:29 UTC 2023
Edited
by admin
on Fri Dec 15 16:33:29 UTC 2023
Record UNII
I670DAL4SZ
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CHLORPHENESIN
INCI   INN   MART.   MI   VANDF   WHO-DD  
INN   INCI  
Official Name English
CHLORPHENESIN [MART.]
Common Name English
CHLORPHENESIN [MI]
Common Name English
Chlorphenesin [WHO-DD]
Common Name English
chlorphenesin [INN]
Common Name English
CHLORPHENESIN [VANDF]
Common Name English
NSC-6401
Code English
CHLORPHENESIN [INCI]
Common Name English
Classification Tree Code System Code
WHO-ATC D01AE07
Created by admin on Fri Dec 15 16:33:29 UTC 2023 , Edited by admin on Fri Dec 15 16:33:29 UTC 2023
NCI_THESAURUS C28394
Created by admin on Fri Dec 15 16:33:29 UTC 2023 , Edited by admin on Fri Dec 15 16:33:29 UTC 2023
WHO-VATC QD01AE07
Created by admin on Fri Dec 15 16:33:29 UTC 2023 , Edited by admin on Fri Dec 15 16:33:29 UTC 2023
Code System Code Type Description
DRUG BANK
DB00856
Created by admin on Fri Dec 15 16:33:29 UTC 2023 , Edited by admin on Fri Dec 15 16:33:29 UTC 2023
PRIMARY
NCI_THESAURUS
C77041
Created by admin on Fri Dec 15 16:33:29 UTC 2023 , Edited by admin on Fri Dec 15 16:33:29 UTC 2023
PRIMARY
NSC
6401
Created by admin on Fri Dec 15 16:33:29 UTC 2023 , Edited by admin on Fri Dec 15 16:33:29 UTC 2023
PRIMARY
RXCUI
2399
Created by admin on Fri Dec 15 16:33:29 UTC 2023 , Edited by admin on Fri Dec 15 16:33:29 UTC 2023
PRIMARY RxNorm
EPA CompTox
DTXSID0049028
Created by admin on Fri Dec 15 16:33:29 UTC 2023 , Edited by admin on Fri Dec 15 16:33:29 UTC 2023
PRIMARY
EVMPD
SUB06202MIG
Created by admin on Fri Dec 15 16:33:29 UTC 2023 , Edited by admin on Fri Dec 15 16:33:29 UTC 2023
PRIMARY
CHEBI
3642
Created by admin on Fri Dec 15 16:33:29 UTC 2023 , Edited by admin on Fri Dec 15 16:33:29 UTC 2023
PRIMARY
FDA UNII
I670DAL4SZ
Created by admin on Fri Dec 15 16:33:29 UTC 2023 , Edited by admin on Fri Dec 15 16:33:29 UTC 2023
PRIMARY
MESH
D002743
Created by admin on Fri Dec 15 16:33:29 UTC 2023 , Edited by admin on Fri Dec 15 16:33:29 UTC 2023
PRIMARY
INN
825
Created by admin on Fri Dec 15 16:33:29 UTC 2023 , Edited by admin on Fri Dec 15 16:33:29 UTC 2023
PRIMARY
CAS
104-29-0
Created by admin on Fri Dec 15 16:33:29 UTC 2023 , Edited by admin on Fri Dec 15 16:33:29 UTC 2023
PRIMARY
SMS_ID
100000081871
Created by admin on Fri Dec 15 16:33:29 UTC 2023 , Edited by admin on Fri Dec 15 16:33:29 UTC 2023
PRIMARY
DAILYMED
I670DAL4SZ
Created by admin on Fri Dec 15 16:33:29 UTC 2023 , Edited by admin on Fri Dec 15 16:33:29 UTC 2023
PRIMARY
CHEBI
59480
Created by admin on Fri Dec 15 16:33:29 UTC 2023 , Edited by admin on Fri Dec 15 16:33:29 UTC 2023
PRIMARY
PUBCHEM
7697
Created by admin on Fri Dec 15 16:33:29 UTC 2023 , Edited by admin on Fri Dec 15 16:33:29 UTC 2023
PRIMARY
ECHA (EC/EINECS)
203-192-6
Created by admin on Fri Dec 15 16:33:29 UTC 2023 , Edited by admin on Fri Dec 15 16:33:29 UTC 2023
PRIMARY
ChEMBL
CHEMBL607710
Created by admin on Fri Dec 15 16:33:29 UTC 2023 , Edited by admin on Fri Dec 15 16:33:29 UTC 2023
PRIMARY
MERCK INDEX
m3454
Created by admin on Fri Dec 15 16:33:29 UTC 2023 , Edited by admin on Fri Dec 15 16:33:29 UTC 2023
PRIMARY Merck Index
Related Record Type Details
ENANTIOMER -> RACEMATE
ENANTIOMER -> RACEMATE
Related Record Type Details
ACTIVE MOIETY